Unknown

Dataset Information

Radiotherapy combined with locoregional hyperthermia for oligoprogression in metastatic melanoma local control.


ABSTRACT:

Background

The evidence base for the management of oligoprogression in metastatic melanoma (MM) is limited. To our knowledge, this study presents the first analysis of the local benefit (LB) of radiotherapy combined with hyperthermia during systemic treatment in this diagnosis.

Methods

Patients with oligoprogressive MM who were treated with radiotherapy (RTH) combined with hyperthermia (HT) at a melanoma center between 2019 and 2023 were evaluated. Oligoprogression was defined as up to five progressive metastases. Inclusion criteria was the availability of dimensions assessment of the lesion subjected to RTH before and after treatment, patients without follow-up imaging after radiotherapy were excluded. The benefit of RTH + HT was evaluated in terms of local control (LC) rat

SUBMITTER: Borkowska AM 

PROVIDER: S-EPMC11815812 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature